Showing 16,781 - 16,800 results of 152,992 for search '(( a we decrease ) OR ( 5 ((point decrease) OR (((mean decrease) OR (a decrease)))) ))', query time: 1.96s Refine Results
  1. 16781

    Reversible Activation of a Cell-Penetrating Peptide in a Membrane Environment by Denise K. Schach (1522021)

    Published 2015
    “…Below pH 6, the sequence folds into a helix and can disrupt membranes. In this study, we show that the lipid bilayer radius-of-curvature has a negligible effect on GALA-induced leakage kinetics and that GALA remains pH responsive after inserting into a lipid membrane. …”
  2. 16782

    Reversible Activation of a Cell-Penetrating Peptide in a Membrane Environment by Denise K. Schach (1522021)

    Published 2015
    “…Below pH 6, the sequence folds into a helix and can disrupt membranes. In this study, we show that the lipid bilayer radius-of-curvature has a negligible effect on GALA-induced leakage kinetics and that GALA remains pH responsive after inserting into a lipid membrane. …”
  3. 16783

    Mammalian OPN5 is a UV light-sensitive photopigment with 11-<i>cis</i>-retinal bound and exhibits a bistable nature. by Daisuke Kojima (201720)

    Published 2011
    “…<p>(A) Absorption spectra of mouse OPN5 (Dark) and its photoproduct (Light). …”
  4. 16784
  5. 16785
  6. 16786

    Hydrodynamic Characterization of Phase Separation in Devices with Microfabricated Capillaries by Anand N. P. Radhakrishnan (6823991)

    Published 2019
    “…The trailing edge of the liquid slugs (receding meniscus) approached the advancing meniscus at a constant speed, thus leading to a linear decrease of the liquid slug length. …”
  7. 16787

    Hydrodynamic Characterization of Phase Separation in Devices with Microfabricated Capillaries by Anand N. P. Radhakrishnan (6823991)

    Published 2019
    “…The trailing edge of the liquid slugs (receding meniscus) approached the advancing meniscus at a constant speed, thus leading to a linear decrease of the liquid slug length. …”
  8. 16788

    The YPLL rate of countries with available data. by Wan Shakira Rodzlan Hasani (9331205)

    Published 2023
    “…Over the past three decades (1990–2022), there has been a slight increase in the YPLL rate and the SEYLL rate for overall CVD and ischemic heart disease but a slight decrease in the SEYLL rate for cerebrovascular disease. …”
  9. 16789

    Characteristics of selected studies. by Wan Shakira Rodzlan Hasani (9331205)

    Published 2023
    “…Over the past three decades (1990–2022), there has been a slight increase in the YPLL rate and the SEYLL rate for overall CVD and ischemic heart disease but a slight decrease in the SEYLL rate for cerebrovascular disease. …”
  10. 16790

    The SEYLL rate of countries with available data. by Wan Shakira Rodzlan Hasani (9331205)

    Published 2023
    “…Over the past three decades (1990–2022), there has been a slight increase in the YPLL rate and the SEYLL rate for overall CVD and ischemic heart disease but a slight decrease in the SEYLL rate for cerebrovascular disease. …”
  11. 16791

    Data extraction form. by Wan Shakira Rodzlan Hasani (9331205)

    Published 2023
    “…Over the past three decades (1990–2022), there has been a slight increase in the YPLL rate and the SEYLL rate for overall CVD and ischemic heart disease but a slight decrease in the SEYLL rate for cerebrovascular disease. …”
  12. 16792

    Patterns of SEYLL rate by WHO regions. by Wan Shakira Rodzlan Hasani (9331205)

    Published 2023
    “…Over the past three decades (1990–2022), there has been a slight increase in the YPLL rate and the SEYLL rate for overall CVD and ischemic heart disease but a slight decrease in the SEYLL rate for cerebrovascular disease. …”
  13. 16793

    Distribution of selected studies by country. by Wan Shakira Rodzlan Hasani (9331205)

    Published 2023
    “…Over the past three decades (1990–2022), there has been a slight increase in the YPLL rate and the SEYLL rate for overall CVD and ischemic heart disease but a slight decrease in the SEYLL rate for cerebrovascular disease. …”
  14. 16794
  15. 16795
  16. 16796
  17. 16797
  18. 16798
  19. 16799
  20. 16800

    DataSheet_2_A cyclic peptide-based PROTAC induces intracellular degradation of palmitoyltransferase and potently decreases PD-L1 expression in human cervical cancer cells.docx by Yu-Ying Shi (15975992)

    Published 2023
    “…Introduction<p>Our previous research has found that degradation of palmitoyltransferase in tumor cells using a linear peptide PROTAC leads to a significant decrease in PD-L1 expression in tumors. …”